Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-469968
Filing Date
2012-11-14
Accepted
2012-11-14 13:45:05
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398826d10q.htm 10-Q 409457
2 EX-31.1 d398826dex311.htm EX-31.1 6339
3 EX-31.2 d398826dex312.htm EX-31.2 6318
4 EX-32 d398826dex32.htm EX-32 4747
  Complete submission text file 0001193125-12-469968.txt   3921893

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cxm-20120930.xml EX-101.INS 484157
6 XBRL TAXONOMY EXTENSION SCHEMA cxm-20120930.xsd EX-101.SCH 46160
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cxm-20120930_cal.xml EX-101.CAL 64134
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cxm-20120930_def.xml EX-101.DEF 158898
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cxm-20120930_lab.xml EX-101.LAB 343440
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cxm-20120930_pre.xml EX-101.PRE 254864
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 121202978
SIC: 2836 Biological Products, (No Diagnostic Substances)